Zobrazeno 1 - 10
of 121
pro vyhledávání: '"V Carinci"'
Publikováno v:
EP Europace. 24
Funding Acknowledgements Type of funding sources: None. Background The occurrence of a sustained monomorphic ventricular tachycardias (SMVT) in patients with underlying structural heart disease (SHD) is considered correlated to a poor prognosis, base
Publikováno v:
EP Europace. 24
Funding Acknowledgements Type of funding sources: None. Background Aortic valve replacement (AVR) is a common procedure. While conduction disturbances are well-recognized complications, ventricular tachycardias (VTs) have not been widely reported nei
Publikováno v:
European Heart Journal Supplements. 24
Background Sacubitril/Valsartan (SV) has been validated for heart failure (HF) with reduced ejection fraction (EF) treatment. SV is effective on hard end–points as well as symptoms and heart remodeling. Present guidelines reccomend at least 3 month
Autor:
L Piscitelli, C Pedone, E Perugini, G Coutsoumbas, L Riva, G Dattolo, V Carinci, G Barbato, L Cardelli, G Casella
Publikováno v:
European Heart Journal Supplements. 24
Background There is an increasing awareness of the association between mitral valve prolapse (MVP) and sudden cardiac death (SCD), but risk stratification is still challenging. Mitral annular disjunction (MAD) is a recognized risk factor for arrhythm
Autor:
Lorenzo Gamberini, Gianni Casella, Giuseppe Di Pasquale, Giovanni Gordini, V. Carinci, Carlo Coniglio
Publikováno v:
The Journal of Emergency Medicine. 58:677-681
Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare channelopathy involving cardiac calcium metabolism that often shows up at an early age with misleading clinical symptoms, such as emotion- or exercise-related syncope w
Autor:
Pietro Delise, V. Carinci
Publikováno v:
Sport-related sudden cardiac death ISBN: 9783030804466
Sport-related sudden cardiac death
Sport-related sudden cardiac death
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92cbdb2e1ad68cade3f1cf64f1077d08
https://doi.org/10.1007/978-3-030-80447-3_12
https://doi.org/10.1007/978-3-030-80447-3_12
Publikováno v:
European Heart Journal. 42
Background Sacubitril/Valsartan (SV) has recently been validated in the therapy of heart failure (HF) with reduced ejection fraction (EF). SV is effective on symptoms and heart remodeling. At the moment the best timing to EF assessment after SV initi
Autor:
Marco Zardini, Daniele Giacopelli, G Bolognesi, Davide Saporito, Giuseppe Allocca, D Grassini, V. Carinci, Matteo Ziacchi, Ernesto Ammendola, Valeria Calvi, E De Maria, Mauro Biffi, Davide Giorgi, Matteo Iori, Giulio Boggian
Publikováno v:
European Heart Journal. 42
Background Automatic diagnosis of implantable cardioverter defibrillator (ICD) requires confirmation through analysis of electrograms (EGM) recordings by an electrophysiologist (EP) specialist. Purpose To investigate whether the atrial sensing capabi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Attilio Pierantozzi, Giovanni Licciardello, Maria Lucia Narducci, Biagio Sassone, Cristian Martignani, Sergio Setti, Gianfranco Ciaramitaro, T Infusino, Davide Caruso, Carlotta Terzaghi, Ernesto Ammendola, Pasquale Notarstefano, Leonardo Calò, V. Carinci, Gennaro Miracapillo, Mauro Biffi, C Ferretti, Massimo Zoni-Berisso, Maurizio Malacrida, Mauro Zennaro
Background Device replacement is the ideal time to reassess health care goals regarding continuing implantable cardioverter-defibrillator (ICD) therapy. Only few data are available on the decision making at this time. Objectives The goals of this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1492d405bd6708fb0328b002b4dbd33
http://hdl.handle.net/11392/2460965
http://hdl.handle.net/11392/2460965